Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
HCPCS code
Name of the Procedure:
Granisetron Hydrochloride Oral Administration
Common Names: Granisetron, Kytril (brand name)
Technical/Medical Term: Granisetron HCl, 1 mg, oral
Summary
Granisetron Hydrochloride taken orally is a medication used to prevent nausea and vomiting caused by chemotherapy. It is a convenient, FDA-approved pill that works as well as intravenous (IV) anti-emetics, but in a more straightforward form of a daily dosage.
Purpose
Granisetron Hydrochloride is used to address:
- Nausea and vomiting associated with chemotherapy.
The primary goal is to provide effective relief from chemotherapy-induced nausea and vomiting, improving patient comfort and the ability to continue cancer treatment.
Indications
Granisetron HCl is indicated for:
- Patients undergoing chemotherapy who experience or are at risk for nausea and vomiting.
- Patients who require an anti-emetic that can be taken orally as opposed to intravenously.
Preparation
- Patients may be advised to refrain from eating for a few hours before taking the medication.
- Inform the healthcare provider of any other medications or supplements being taken.
- No specific diagnostic tests required beforehand, but a medical history review will likely be conducted.
Procedure Description
- The patient receives a prescription for Granisetron Hydrochloride from their healthcare provider.
- The medication is taken orally with water.
- Typically, the dose is 1 mg and administered once daily.
- The medication should be taken at least one hour before the start of chemotherapy.
- No anesthesia or sedation is necessary, as it is an oral medication.
Duration
The medication is typically taken once a day and should be consumed no more than 24 hours after the time of chemotherapy treatment.
Setting
Granisetron Hydrochloride can be taken in any setting, including at home, work, or at a healthcare facility, as per convenience.
Personnel
- Prescribed by an oncologist or a healthcare provider.
- No additional medical personnel is needed for administration.
Risks and Complications
- Common Risks: Headache, constipation, or diarrhea.
- Rare Risks: Severe allergic reactions, changes in heart rhythm.
Management includes symptomatic treatments for mild side effects and immediate medical attention for any severe reactions.
Benefits
- Rapid onset of action to prevent nausea and vomiting.
- Convenience of oral administration.
- Reduced need for IV anti-emetics, which can be more complicated and invasive.
Patients generally experience relief within a few hours of administration.
Recovery
- No specific recovery process as it is an oral medication.
- Patients should follow any additional instructions from their healthcare provider and report any side effects encountered.
- Regular follow-up appointments may help monitor overall treatment effectiveness.
Alternatives
- Other oral anti-emetics (e.g., ondansetron, aprepitant).
- IV anti-emetics, which may be needed if oral medication is not effective.
- Non-pharmacological options like acupuncture or dietary changes, though less common.
Pros: Oral medication offers ease of use and avoids the invasiveness of IV treatment.
Cons: Oral medication may not be suitable for patients who have difficulty swallowing pills or for those who need rapid relief that only an IV can provide.
Patient Experience
- Patients will take the medication orally and should not experience pain during this process.
- They might experience mild side effects such as headaches or gastrointestinal discomfort, which are manageable.
- Relief from chemotherapy-induced nausea and vomiting dramatically enhances overall comfort and quality of life during cancer treatment.